Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Apr/23/2021 13 1
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 6 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Curcumin Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021 6 0
Tizoxanide Potential treatment - theoretical effect Experimental Antiviral Jan/25/2021 1 0
Dolutegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Jan/25/2021 5 0